Neoplasm Metastasis: all 3,564 studies
Page 27 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer PatientsTerminatedNCT02454855Phase 3
- Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone MetastasesActive, not recruitingNCT02454543Not applicable
- Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver MetastasisTerminatedNCT02453490Phase 3
- Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)Status unknownNCT02452294Phase 2
- A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic CancersTerminatedNCT02452268Phase 1
- A Study of CriPec® Docetaxel Given to Patients With Solid TumoursCompletedNCT02442531Phase 1
- Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer PatientsWithdrawnNCT02441270Early Phase 1
- Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable MetastasisCompletedNCT02439385Phase 2
- Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following RadiosurgeryTerminatedNCT02433171
- Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)CompletedNCT02430766Not applicable
- Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary PreventionCompletedNCT02430012Not applicable
- Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node MetastasesCompletedNCT02426879Not applicable
- CBT Plus SMC Compared to SMC for Persistent Physical Symptoms in Secondary Care (PRINCE)CompletedNCT02426788Not applicable
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver MetastasesCompletedNCT02419677Phase 2/3
- CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver MetastasesCompletedNCT02416466Phase 1
- Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate CancerCompletedNCT02415621Early Phase 1
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
- Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid MalignancyCompletedNCT02412462Phase 1
- Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate CancerCompletedNCT02410044
- Negative Pressure Wound Therapy in Groin DissectionStatus unknownNCT02408835Not applicable
- Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal MetastasesTerminatedNCT02407795Not applicable
- Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric CarcinomaCompletedNCT02406170Phase 1/2
- Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone MetastasesCompletedNCT02398526
- A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-NorwayStatus unknownNCT02395224
- Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain MetastasesStatus unknownNCT02393131Not applicable
- Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid CancerCompletedNCT02390934Phase 2
- Reducing Secondary Distress in Violence Researchers: a Randomised Trial of the Effectiveness of Group Debriefings.CompletedNCT02390778Not applicable
- Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal MetastasesActive, not recruitingNCT02387905Phase 2
- Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1TerminatedNCT02387125Phase 1
- Oral Piroxicam Versus Buccal Fentanyl in Breakthrough PainCompletedNCT02382653Not applicable
- Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver MetastasisStatus unknownNCT02380131Phase 4
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPSCompletedNCT02376322Phase 2
- Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC PatientsCompletedNCT02374411
- Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain MetastasesActive, not recruitingNCT02374242Phase 2
- Minimally Invasive Surgery (MIS) for Spine MetastasesCompletedNCT02367378
- A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingCompletedNCT02364531
- Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL StudyCompletedNCT02364115Not applicable
- Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon CancerStatus unknownNCT02363049Phase 3
- Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone MetastasesStatus unknownNCT02358720Phase 1/2
- Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's PhenomenonStatus unknownNCT02356809Phase 1/2
- Comparative Evaluation of Two Different RadiosurgeryCompletedNCT02355613Not applicable
- Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT02355353Not applicable
- Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain MetastasesTerminatedNCT02353000Not applicable
- Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid CancerStatus unknownNCT02352571Phase 1
- Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid TumorsCompletedNCT02342158Not applicable
- Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis PatientsStatus unknownNCT02338934Phase 4
- Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)Status unknownNCT02338011Phase 2/3
- The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing HemodialysisStatus unknownNCT02332135Not applicable
- Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.CompletedNCT02331641
- Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple SclerosisCompletedNCT02330965
- FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain LesionsWithdrawnNCT02328300
- Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying LesionStatus unknownNCT02327065Not applicable
- Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerActive, not recruitingNCT02321501Phase 1
- Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)CompletedNCT02316028Phase 1/2
- Safety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsTerminatedNCT02313012Phase 1
- Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance ImagingCompletedNCT02311556Phase 1
- Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)Status unknownNCT02311205Phase 2
- The NOR-COR Study for Coronary PreventionCompletedNCT02309255
- Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)CompletedNCT02308137Phase 2
- Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic AlterationsActive, not recruitingNCT02304809Phase 2
- Identification of Predictive and Prognostic Markers for Lung Cancer With MetastasesActive, not recruitingNCT02301858Not applicable
- Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerActive, not recruitingNCT02298959Phase 1
- Bone Pain Score Validation InitiativeCompletedNCT02293642
- Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA GenesActive, not recruitingNCT02286687Phase 2
- Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment MethodCompletedNCT02286037
- High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesStatus unknownNCT02284490Phase 2
- Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesTerminatedNCT02279992Early Phase 1
- Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)CompletedNCT02277587Phase 4
- The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)CompletedNCT02273713Phase 1/2
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)Status unknownNCT02273570Not applicable
- Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain MetastasesCompletedNCT02265549
- Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer PatientsStatus unknownNCT02251353
- Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLCStatus unknownNCT02250846Phase 2
- A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody DeficiencyCompletedNCT02247154Phase 4
- Diffusion-Weighted Magnetic Resonance ImagingStatus unknownNCT02242786Phase 2
- Phase I Study on VEGF Vaccination in Metastatic Solid TumorsCompletedNCT02237638Phase 1
- Development of a New Tool for Dyspnea Measurement in Chronic Respiratory DiseasesCompletedNCT02229994
- Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02228850Phase 2
- Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic CancerStatus unknownNCT02228356
- Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple SclerosisCompletedNCT02228213Phase 2
- Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic TreatmentStatus unknownNCT02226289Phase 2
- Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain MetastasesCompletedNCT02220491Not applicable
- A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance ProgramCompletedNCT02218801
- The STAR Prospective Clinical SeriesCompletedNCT02217150
- Phase 2 Study of KHK7580CompletedNCT02216656Phase 2
- ALPPS Versus PVE/PLStatus unknownNCT02215577Not applicable
- Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain MetastasesCompletedNCT02215512Phase 1
- Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron DeficiencyTerminatedNCT02213653Phase 4
- Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 RadioembolizationStatus unknownNCT02208804Phase 2/3
- Phase III Radium 223 mCRPC-PEACE IIIActive, not recruitingNCT02194842Phase 3
- Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain MetastasesTerminatedNCT02187822Phase 1
- Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesStatus unknownNCT02185352Phase 2
- Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary HypertensionCompletedNCT02184858Phase 4
- Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic CancerCompletedNCT02184533Phase 1
- Whole-body MRI for the Detection of MetastasisWithdrawnNCT02183597
- Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus BevacizumabTerminatedNCT02175654Phase 2
- Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.TerminatedNCT02174107Not applicable
- Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese PatientsCompletedNCT02172690Not applicable
- Stereotactic Radiosurgery in Metastatic Spinal Cord CompressionTerminatedNCT02167633Not applicable